title: American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning.
abstract: The seminal report from the Institute of Medicine, "From Cancer Patient to Cancer Survivor: Lost in Transition," identified four essential components of survivorship care and recommended that a survivorship care plan (SCP), consisting of a treatment summary and follow-up care plan, be developed and used as a tool to deliver patient-centered care by enhancing communication between the oncology team and the patient as well as communication and coordination of care between the oncology team and the primary care provider (PCP). Nearly a decade ago, the American Society of Clinical Oncology (ASCO) initiated a series of activities to promote chemotherapy treatment plans and summaries and SCPs. Unfortunately, there has been limited success in implementing SCPs in oncology practice because of barriers including, but not limited to, the time-consuming process of completing an SCP, lack of role clarity, and lack of reimbursement for preparation time. ASCO developed this statement and revised template to provide a framework for completing and sharing SCPs and to set clear expectations for survivorship care planning in the oncology setting. This statement is intended to help clinicians recognize the importance of developing patient-centered SCPs and delivering the information to both the patient and PCP and to identify barriers that may exist in completing and delivering these documents effectively.
authors.affiliation: University of North Carolina, Chapel Hill, NC; Harvard Medical School and Harvard Vanguard Medical Associates; Dana Farber Cancer Institute, Boston, MA; Johns Hopkins School of Medicine, Baltimore, MD; and American Society of Clinical Oncology, Alexandria, VA. dmayer@unc.edu.
authors.forename: Deborah K
authors.initials: DK
authors.lastname: Mayer
authors.affiliation: University of North Carolina, Chapel Hill, NC; Harvard Medical School and Harvard Vanguard Medical Associates; Dana Farber Cancer Institute, Boston, MA; Johns Hopkins School of Medicine, Baltimore, MD; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Larissa
authors.initials: L
authors.lastname: Nekhlyudov
authors.affiliation: University of North Carolina, Chapel Hill, NC; Harvard Medical School and Harvard Vanguard Medical Associates; Dana Farber Cancer Institute, Boston, MA; Johns Hopkins School of Medicine, Baltimore, MD; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Claire F
authors.initials: CF
authors.lastname: Snyder
authors.affiliation: University of North Carolina, Chapel Hill, NC; Harvard Medical School and Harvard Vanguard Medical Associates; Dana Farber Cancer Institute, Boston, MA; Johns Hopkins School of Medicine, Baltimore, MD; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Janette K
authors.initials: JK
authors.lastname: Merrill
authors.affiliation: University of North Carolina, Chapel Hill, NC; Harvard Medical School and Harvard Vanguard Medical Associates; Dana Farber Cancer Institute, Boston, MA; Johns Hopkins School of Medicine, Baltimore, MD; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Dana S
authors.initials: DS
authors.lastname: Wollins
authors.affiliation: University of North Carolina, Chapel Hill, NC; Harvard Medical School and Harvard Vanguard Medical Associates; Dana Farber Cancer Institute, Boston, MA; Johns Hopkins School of Medicine, Baltimore, MD; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Lawrence N
authors.initials: LN
authors.lastname: Shulman
mesh_terms: D020811:Biomedical Technology; D032921:Consensus; D003695:Delivery of Health Care; D006284:Health Plan Implementation; D006295:Health Resources / Q000706:statistics & numerical data; D006801:Humans; D007400:Interprofessional Relations; D008134:Long-Term Care / Q000458:organization & administration; D008495:Medical Oncology; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D009369:Neoplasms / Q000628:therapy*; D010347:Patient Care Planning / Q000458:organization & administration*; D010353:Patient Education as Topic; D010360:Patient Transfer; D018802:Patient-Centered Care / Q000458:organization & administration*; D012955:Societies, Medical; D017741:Survivors; D014481:United States